// App-Quantinova.ai

258 : MicroRNAs as biomarkers of resistance to HER2 inhibition in combination with chemotherapy in gastro-esophageal cancer

Researchers

Presenter

  • Hazel Lote

Principal Investigators

  • Andrea Lampis

  • George Vlachogiannis

  • Jens Hahne

  • Sing-Yu Moorcraft

  • Michael Davidson

  • Carolin Fong

  • Ruwaida Begum

  • Matteo Fassan

  • Sheela Rao

  • David Watkins

  • Naureen Starling

  • Ian Chau

  • David Cunningham

  • Nicola Valeri

Medical Centers

  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  • Institute for Cancer Research, London, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • University of Pavia, Pavia, Italy

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Esophageal Cancer

Biomarkers

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Trastuzumab

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02112357

  • NCT02678182

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved